European diabetes research has declined as a proportion of world output from 45% of world output in 2002 to 33% in 2015 while the burden has increased from 2% to 2.6% of DALYs in 10 years. • Outputs mostly correlate with GDP; Scandinavia performs well except for Norway; France, Lithuania and Romania also also do less well. • Funding between subject areas is variable varies with high levels on Latent Autoimmune Disease of Adults and Maturity Onset Diabetes of the Young; there is very little on foot problems. • Main funding sources are government (30%), private-non-profit (18%, especially in the UK) and industry (13%, notably from Novo Nordisk).
European diabetes research and its funding, 2002–2013
SOMMARIVA, SILVIA;CIANI, ORIANA;TARRICONE, ROSANNA;
2017
Abstract
European diabetes research has declined as a proportion of world output from 45% of world output in 2002 to 33% in 2015 while the burden has increased from 2% to 2.6% of DALYs in 10 years. • Outputs mostly correlate with GDP; Scandinavia performs well except for Norway; France, Lithuania and Romania also also do less well. • Funding between subject areas is variable varies with high levels on Latent Autoimmune Disease of Adults and Maturity Onset Diabetes of the Young; there is very little on foot problems. • Main funding sources are government (30%), private-non-profit (18%, especially in the UK) and industry (13%, notably from Novo Nordisk).
| File | Dimensione | Formato | |
|---|---|---|---|
|
Begum_et_al-2017-Diabetic_Medicine.pdf
non disponibili
Tipologia:
Documento in Post-print (Post-print document)
Licenza:
NON PUBBLICO - Accesso privato/ristretto
Dimensione
153.12 kB
Formato
Adobe PDF
|
153.12 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
